K191382 is an FDA 510(k) clearance for the IPS e.max CAD Abutment Solutions- extra systems. This device is classified as a Abutment, Implant, Dental, Endosseous (Class II - Special Controls, product code NHA).
Submitted by Ivoclar Vivadent, AG (Schaan, LI). The FDA issued a Cleared decision on August 26, 2019, 95 days after receiving the submission on May 23, 2019.
This device falls under the Dental FDA review panel. Regulated under 21 CFR 872.3630. To Be Used In Conjunction With An Endosseous Dental Implant Fixture To Aid In Prosthetic Rehabilitation..